MARKET

AMRS

AMRS

Amyris
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.78
-0.05
-0.33%
Opening 14:22 02/26 EST
OPEN
14.08
PREV CLOSE
13.82
HIGH
15.21
LOW
13.38
VOLUME
2.42M
TURNOVER
--
52 WEEK HIGH
18.57
52 WEEK LOW
1.400
MARKET CAP
3.30B
P/E (TTM)
-7.3671
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
--Analyst Actions: Roth Capital Initiates Coverage on Amyris at Buy Rating, Sets Price Target at $20
MT Newswires · 6h ago
Global Nutraceutical Products Market Size 2021, by Product Type, Disease Indication: Covid 19 Impact Outlook and Forecast-2026
Feb 25, 2021 (The Expresswire) -- Global Nutraceutical Products Market 2020 By Product Type (USP Standards Grade, EP Standards Grade, Pharmaceutical...
The Express Wire · 1d ago
Natural Sweeteners Market Top 10 Key Players, Demand, Revenue, Growth Factors by Types, Trends, Porters Five Force Analysis and Forecast till 2027
Feb 25, 2021 (The Expresswire) -- The natural sweeteners market to witness high demand due to the increasing awareness about health benefits associated with...
The Express Wire · 1d ago
Amyris Announces Participation In Upcoming Investor Conferences
EMERYVILLE, Calif., Feb. 25, 2021 /PRNewswire via COMTEX/ -- EMERYVILLE, Calif., Feb. 25, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading...
PR Newswire - PRF · 1d ago
Synthetic Biology Market Research Revealing the Growth Rate and Business Opportunities to 2027
Heraldkeepers · 1d ago
BRIEF-Amyris Says Pipette Clean Baby Care Brand To Expand Retail Presence In Over 600 Target Stores Across North America
reuters.com · 2d ago
Amyris Announces Launch Of Pipette Clean Baby Care Brand In Target Retail Stores Across North America
EMERYVILLE, Calif., Feb. 24, 2021 /PRNewswire/ -- Amyris, Inc. (NASDAQ:AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands and a top
Benzinga · 2d ago
Amyris launches Pipette® clean baby care brand in 600 Target retail stores across North America
Amyris (AMRS) +8.5% premarket, has launched Pipette lean baby care brand in more than 600 Target stores across North America, beginning in March 2021. "We are very excited to partner with Target to
Seekingalpha · 2d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AMRS. Analyze the recent business situations of Amyris through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AMRS stock price target is 12.00 with a high estimate of 17.00 and a low estimate of 6.00.
EPS
Institutional Holdings
Institutions: 189
Institutional Holdings: 100.14M
% Owned: 41.86%
Shares Outstanding: 239.21M
TypeInstitutionsShares
Increased
51
14.78M
New
56
-11.68M
Decreased
16
7.78M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Commodity Chemicals
-0.44%
Chemicals
-0.83%
Key Executives
Chairman/Independent Director
Geoffrey Duyk
Chief Executive Officer/President/Director
John Melo
Corporate Executive
Oreste Fieschi
Chief Financial Officer
Han Kieftenbeld
Chief Operating Officer
Eduardo Alvarez
Chief Accounting Officer
Anthony Hughes
Chief Marketing Officer
Sheila Pollak
General Counsel/Secretary
Nicole Kelsey
Other
Kathleen Valiasek
Director
Philip Eykerman
Director
Christoph Goppelsroeder
Director
Julie Washington
Independent Director
John Doerr
Independent Director
Frank Kung
Independent Director
James McCann
Independent Director
Steven Mills
Independent Director
Carole Piwnica
Independent Director
Lisa Qi
Independent Director
Patrick Yang
  • Dividends
  • Splits
  • Insider Activity
No Data
About AMRS
Amyris, Inc. is an industrial biotechnology company. The Company is primarily focused on applying its technology platform to engineer, manufacture and sell high performance, natural, sustainably-sourced products into the Health & Wellness, Clean Beauty, and Flavor and Fragrance markets. Its technology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into volume, high-value ingredients. Its biotechnology platform and industrial fermentation process replace existing complex and expensive manufacturing processes. The Company’s platform is used to design, build, optimize and upscale strains producing eight distinct molecules at commercial volumes, to more than 15 commercial ingredients.

Webull offers kinds of Amyris Inc stock information, including NASDAQ:AMRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AMRS stock methods without spending real money on the virtual paper trading platform.